Speaker Profile

Dr. Silvia C. Sookoian

Dr. Silvia C. Sookoian, MD, PhD, FAASLD

Institute of Medical Research (IDIM), School of Medicine, University of Buenos Aires and National Scientific and Technical Research Council (CONICET), Clinical and Molecular Hepatology

<p>Staff Researcher. National Scientific and Technical Research Council (CONICET). She has a position as a physician scientist devoted to translate scientific knowledge in Hepatology into the patients care. Her current clinical and translational research is focused on genetic, epigenetic and molecular mechanisms implicated in non-alcoholic fatty liver disease (NAFLD) pathogenesis and disease progression. Dr. Sookoian has published extensively in the field of Liver Diseases, including NAFLD and hepatitis C. She has been in clinical practice since 1987 (Clinical Training Board certificated in Internal Medicine; Fellowship in Hepatology). She received training in Hepatology (Karolinska Institute, Huddinge University Hospital. Sweden.Hepatology Centers of Excellence Program; Pathology (Armed Forces Institute of Pathology. Washington DC.); Genetics of complex diseases (Cold Spring Harbor Laboratories. NY, USA, and Wellcome Trust Advanced Courses).</p>

Abstracts

Sessions

Basic Science Symposium. PART 2: Transcriptomics, Epigenomics and Liver Disease

Date: Saturday, November 5th

Time: 9:30 - 10:45 AM EDT

Meet The Experts 20: Precision medicine applied to NAFLD

Date: Sunday, November 6th

Time: 1:15 - 2:00 PM EST

Parallel 12: NASH therapeutics and OMICs

Date: Sunday, November 6th

Time: 2:00 - 3:30 PM EST

Pan-society Presentation of NAFLD Nomenclature Consensus Process

Date: Sunday, November 6th

Time: 4:00 - 6:00 PM EST